Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate withdrawal study in children with ADHD
NL-OMON41851Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Continued methylphenidate with Withdrawal to placebo (2 arms). Primary endpoint: ADHD-DSM-5 RS. Planned start Sep 2015; status: not yet recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON41851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41851.